HUE036272T2 - Nalmefén alkoholfogyasztás csökkentésére specifikus célcsoportok esetében - Google Patents

Nalmefén alkoholfogyasztás csökkentésére specifikus célcsoportok esetében

Info

Publication number
HUE036272T2
HUE036272T2 HUE16187426A HUE16187426A HUE036272T2 HU E036272 T2 HUE036272 T2 HU E036272T2 HU E16187426 A HUE16187426 A HU E16187426A HU E16187426 A HUE16187426 A HU E16187426A HU E036272 T2 HUE036272 T2 HU E036272T2
Authority
HU
Hungary
Prior art keywords
nalmefene
specific target
alcohol consumption
target groups
reducing alcohol
Prior art date
Application number
HUE16187426A
Other languages
English (en)
Hungarian (hu)
Inventor
Lars Torup
Afsaneh Abbariki
Anna Bladstroem
Christine Persson
Didier Meulien
Per Soerensen
Thomas Jensen
Jette Oestergaard
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE036272(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of HUE036272T2 publication Critical patent/HUE036272T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HUE16187426A 2012-06-27 2013-06-27 Nalmefén alkoholfogyasztás csökkentésére specifikus célcsoportok esetében HUE036272T2 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261664804P 2012-06-27 2012-06-27
US201261721539P 2012-11-02 2012-11-02
US201261736740P 2012-12-13 2012-12-13
US201361788810P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
HUE036272T2 true HUE036272T2 (hu) 2018-06-28

Family

ID=48703496

Family Applications (4)

Application Number Title Priority Date Filing Date
HUE23163177A HUE070621T2 (hu) 2012-06-27 2013-06-27 Nalmefén alkoholfogyasztás csökkentésére specifikus célpopulációkban
HUE16187426A HUE036272T2 (hu) 2012-06-27 2013-06-27 Nalmefén alkoholfogyasztás csökkentésére specifikus célcsoportok esetében
HUE13732471A HUE031110T2 (en) 2012-06-27 2013-06-27 Nalmefene for reduction of alcohol consumption in specific target populations
HUE17206034A HUE063313T2 (hu) 2012-06-27 2013-06-27 Nalmefén alkoholfogyasztás csökkentésére specifikus célcsoportok esetében

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE23163177A HUE070621T2 (hu) 2012-06-27 2013-06-27 Nalmefén alkoholfogyasztás csökkentésére specifikus célpopulációkban

Family Applications After (2)

Application Number Title Priority Date Filing Date
HUE13732471A HUE031110T2 (en) 2012-06-27 2013-06-27 Nalmefene for reduction of alcohol consumption in specific target populations
HUE17206034A HUE063313T2 (hu) 2012-06-27 2013-06-27 Nalmefén alkoholfogyasztás csökkentésére specifikus célcsoportok esetében

Country Status (35)

Country Link
US (4) US20140005217A1 (enExample)
EP (5) EP4223296B1 (enExample)
JP (3) JP6258933B2 (enExample)
KR (1) KR20150023396A (enExample)
CN (1) CN104411313A (enExample)
AU (1) AU2013283281B2 (enExample)
BR (1) BR112014032555A2 (enExample)
CA (1) CA2874703C (enExample)
CL (1) CL2014003484A1 (enExample)
CO (1) CO7160087A2 (enExample)
CY (3) CY1118579T1 (enExample)
DK (3) DK3138564T3 (enExample)
EA (1) EA029908B1 (enExample)
ES (4) ES2663532T3 (enExample)
FI (1) FI3345604T3 (enExample)
HK (1) HK1255683A1 (enExample)
HR (4) HRP20230762T8 (enExample)
HU (4) HUE070621T2 (enExample)
IL (1) IL236035B (enExample)
LT (3) LT3138564T (enExample)
ME (2) ME02587B (enExample)
MX (1) MX371373B (enExample)
MY (1) MY166914A (enExample)
NZ (1) NZ702191A (enExample)
PH (1) PH12014502798A1 (enExample)
PL (4) PL3345604T3 (enExample)
PT (3) PT3345604T (enExample)
RS (2) RS57046B1 (enExample)
RU (1) RU2665373C2 (enExample)
SG (1) SG11201408704WA (enExample)
SI (3) SI2866808T1 (enExample)
SM (3) SMT201600471T1 (enExample)
UA (1) UA114199C2 (enExample)
WO (1) WO2014001427A1 (enExample)
ZA (1) ZA201409525B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
JP6419780B2 (ja) * 2013-04-17 2018-11-07 ハー・ルンドベック・アクチエゼルスカベット 睡眠障害患者の治療のためのナルメフェン
MX2016013889A (es) 2014-04-22 2017-03-09 Otsuka Pharma Co Ltd Medicamento.
US20170071590A1 (en) * 2015-09-10 2017-03-16 Suture Armor Llc Suture anchor
KR102699603B1 (ko) 2018-04-20 2024-08-29 삼성전자주식회사 반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
RU2004107501A (ru) * 2001-08-14 2005-02-20 Байотай Терапис Корпорейшн (Fi) Способ лечения алкоголизма или злоупотребления алкоголем
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
JP5794980B2 (ja) 2009-05-25 2015-10-14 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンからの塩酸ナルメフェンの調製
HRP20170379T1 (hr) 2010-11-05 2017-05-05 H. Lundbeck A/S Postupak proizvodnje naltreksona
WO2012134410A1 (en) 2011-03-31 2012-10-04 Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. Compositions of opioid antagonists and their use for treating scleroderma
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations

Also Published As

Publication number Publication date
HRP20230762T1 (hr) 2023-10-13
MX371373B (es) 2020-01-28
PT3138564T (pt) 2018-04-03
PH12014502798A1 (en) 2015-02-09
US20160375007A1 (en) 2016-12-29
EP2866808A1 (en) 2015-05-06
CO7160087A2 (es) 2015-01-15
SMT201800164T1 (it) 2018-07-17
AU2013283281A1 (en) 2014-12-11
JP6258933B2 (ja) 2018-01-10
RS57046B1 (sr) 2018-05-31
PL3345604T3 (pl) 2023-08-28
AU2013283281B2 (en) 2017-04-20
CY1118579T1 (el) 2017-07-12
MX2014015488A (es) 2015-03-06
EP3138564B1 (en) 2018-01-31
US10034874B2 (en) 2018-07-31
EP2866808B1 (en) 2016-11-02
PL2866808T3 (pl) 2017-04-28
LT3345604T (lt) 2023-08-10
CA2874703A1 (en) 2014-01-03
SI3138564T1 (en) 2018-04-30
MY166914A (en) 2018-07-24
CN104411313A (zh) 2015-03-11
EP4541421A3 (en) 2025-06-18
US20140005217A1 (en) 2014-01-02
PL3138564T3 (pl) 2018-06-29
US20140005216A1 (en) 2014-01-02
HRP20180363T1 (hr) 2018-04-20
HUE031110T2 (en) 2017-06-28
KR20150023396A (ko) 2015-03-05
HK1208185A1 (en) 2016-02-26
RU2665373C2 (ru) 2018-08-29
SI2866808T1 (sl) 2017-01-31
HUE063313T2 (hu) 2024-01-28
HK1255683A1 (en) 2019-08-23
EP4223296A3 (en) 2023-09-27
HUE070621T2 (hu) 2025-06-28
SMT201600471B (it) 2017-03-08
LT2866808T (lt) 2017-01-10
EP3345604B1 (en) 2023-06-07
SI3345604T1 (sl) 2023-08-31
FI3345604T3 (fi) 2023-07-28
ME02587B (me) 2017-06-20
ES2609122T3 (es) 2017-04-18
UA114199C2 (uk) 2017-05-10
JP2019163275A (ja) 2019-09-26
HRP20250329T1 (hr) 2025-05-09
EP3345604A1 (en) 2018-07-11
ES3014068T3 (en) 2025-04-16
EP4223296B1 (en) 2025-01-29
PT2866808T (pt) 2017-01-03
SMT201600471T1 (it) 2017-03-08
ME03030B (me) 2018-10-20
CL2014003484A1 (es) 2015-02-27
PT3345604T (pt) 2023-07-17
DK3138564T3 (en) 2018-03-26
RS55456B1 (sr) 2017-04-28
JP6857684B2 (ja) 2021-04-14
HRP20161717T1 (hr) 2017-02-10
DK3345604T3 (da) 2023-07-24
IL236035A0 (en) 2015-01-29
CY1126140T1 (el) 2023-11-15
US9642849B2 (en) 2017-05-09
ES2663532T3 (es) 2018-04-13
SG11201408704WA (en) 2015-01-29
ZA201409525B (en) 2016-08-31
JP2018039810A (ja) 2018-03-15
PL4223296T3 (pl) 2025-04-14
EP4223296C0 (en) 2025-01-29
CA2874703C (en) 2022-08-23
CY1120097T1 (el) 2018-12-12
DK2866808T3 (en) 2017-01-16
RU2014151156A (ru) 2016-08-20
EP4223296A2 (en) 2023-08-09
EP3138564A1 (en) 2017-03-08
EA201492152A1 (ru) 2015-11-30
LT3138564T (lt) 2018-04-10
ES2950492T3 (es) 2023-10-10
HRP20230762T8 (hr) 2024-01-05
EA029908B1 (ru) 2018-05-31
US20180028526A1 (en) 2018-02-01
NZ702191A (en) 2017-06-30
WO2014001427A1 (en) 2014-01-03
EP4541421A2 (en) 2025-04-23
IL236035B (en) 2018-12-31
JP2015521647A (ja) 2015-07-30
BR112014032555A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
BR112014028331A2 (pt) artigos absorventes com zonas texturizadas
DK2900806T3 (da) Tredimensionel celledyrkning
BR112013022932A2 (pt) painel de utilidade
BR112015005410A2 (pt) artigo fotocrômico-dicróico
EP2739484A4 (en) Graphic article
DK2904088T3 (da) Gas-tilført fermentationssystem
DK3421470T3 (da) Substituerede 5-fluor-1h-pyrazolopyridiner i krytallinsk form
CO6880068A2 (es) Aminoquinazolinas como inhibidores de quinasa
EP2739474A4 (en) Graphic article
EP2705402A4 (en) ADJUSTABLE GLASSES
BR112014002340A2 (pt) artigo gráfico
EP2739485A4 (en) GRAPHIC ARTICLE
EP2764432A4 (en) MOBILE CONTENTS
CO7020914A2 (es) Nievos derivados de morofolinilo útiles como inhibidores de mogat-2
SMT201600471B (it) Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche
KR101198979B9 (ko) 분수용 조명등
IT1403676B1 (it) Manufatti in ferrolega
ES1076698Y (es) Enfriador de cerveza en jarra
UA23399S (uk) Фактурний візерунок
FI20125307L (fi) Bioreaktori
ES1075608Y (es) Monolito inteligente
FR2986895B3 (fr) Article promotionnel positionnable
BR302012006072S1 (pt) Configuracao em conjunto de talheres
FI20110234A0 (fi) Energiansäästölaite